Ligand Pharmaceuticals LGND Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $3.98B.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's market capitalization?
- Ligand Pharmaceuticals (LGND) reported market capitalization of $3.98B in Q1 2026.
- How has Ligand Pharmaceuticals's market capitalization changed year-over-year?
- Ligand Pharmaceuticals's market capitalization increased by 96.7% year-over-year, from $2.02B to $3.98B.
- What is the long-term trend for Ligand Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's market capitalization has grown at a 17.5% compound annual growth rate (CAGR), from $1.66B to $3.72B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.